ProfileGDS4459 / ENSG00000197879
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 62% 66% 72% 55% 61% 61% 71% 66% 65% 72% 63% 70% 74% 67% 68% 32% 49% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.8562
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.0266
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.5372
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.6655
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.8661
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.8161
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.4971
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.166
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.165
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.5472
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.8263
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.4270
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.6274
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.0567
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.2668
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.8432
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.3549